Adaptive Biotechnologies Corporation: Piper Sandler raises target price to $35 from $27.5
ADPT•Piper Sandler raised its target price for Adaptive Biotechnologies Corporation to $35 from $27.5.
Related News
CEVA, Inc.: JP Morgan cuts target price to $35 from $45
CEVA•
Exxon signs preliminary agreement with Venezuela to evaluate oil opportunities
XOM•
Amgen grants director Michael V. Drake 114 restricted stock units that vest immediately
AMGN•
Three workers reportedly die at Tata Electronics' iPhone parts plant
AAPL•
Aussie steadies as oil-fuelled risk rally offsets weak domestic surveys
TLT•